Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study.
<h4>Background</h4>Physicians need to inform asymptomatic individuals about personalized outcomes of statin therapy for primary prevention of cardiovascular disease (CVD). However, current prediction models focus on short-term outcomes and ignore the competing risk of death due to other...
Saved in:
| Main Authors: | Bart S Ferket, Bob J H van Kempen, Jan Heeringa, Sandra Spronk, Kirsten E Fleischmann, Rogier L G Nijhuis, Albert Hofman, Ewout W Steyerberg, M G Myriam Hunink |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1001361&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decision curve analysis: confidence intervals and hypothesis testing for net benefit
by: Andrew J. Vickers, et al.
Published: (2023-06-01) -
Statins and diabetes mellitus: risks and benefits
by: O. M. Drapkina, et al.
Published: (2012-12-01) -
Correction: Decision curve analysis: confidence intervals and hypothesis testing for net benefit
by: Andrew J. Vickers, et al.
Published: (2025-03-01) -
Statin Therapy and Cognitive Impairment: Benefit or Harm?
by: O. D. Ostroumova, et al.
Published: (2018-09-01) -
Reduction of cardiovascular risk in rheumatoid arthritis: double benefit of statins
by: Diana Sergeevna Novikova, et al.
Published: (2010-12-01)